Signs You Need Alpha-Lipoic Acid (ALA): Deficiency & Who Benefits

Why an "ALA deficiency" cannot be measured in a blood test

Alpha-lipoic acid is the only well-known supplement where people ask about deficiency symptoms even though a classical deficiency has never been described. The reason is simple: the body synthesises alpha-lipoic acid itself, in the mitochondria, from octanoic acid and sulfur. Unlike vitamin D or iron, there is no routine test for ALA at your family doctor, and the Estonian Health Board publishes no recommended daily intake for it, because you do not need to obtain it from food.

That does not make the question pointless. Endogenous synthesis covers the coenzyme role — ALA in its bound form, attached to an enzyme — but it does not provide free ALA, which is the part that acts as an antioxidant. The only way to raise free ALA in the blood is to take it. So the question is not "do I have a deficiency" but "am I in a situation where an extra dose changes anything".

In this article we look at what ALA does in the body, which complaints people associate with it, what the research actually shows, which forms are available in Estonia and who should clearly avoid it. One boundary up front: alpha-lipoic acid is a supplement, not a medicine. It does not treat any disease and it does not replace medical supervision.

What alpha-lipoic acid actually does

ALA has two separate roles that are often confused.

The first is the coenzyme role. Lipoic acid is covalently bound to mitochondrial enzyme complexes — the best known being the pyruvate dehydrogenase complex, which converts pyruvate from glycolysis into acetyl-CoA. That is the point where energy from carbohydrate enters the Krebs cycle. The body makes this bound form itself, and supplemental ALA essentially does not reach it.

The second is the free antioxidant role. Orally taken ALA circulates briefly in free form and is reduced in tissues to dihydrolipoic acid. In that form it can neutralise several types of reactive species and, more interestingly, regenerate other already-spent antioxidants such as vitamin C, vitamin E and glutathione. Because it dissolves in both water and fat, it reaches both the aqueous phase of the cell and the membranes — hence the label universal antioxidant (Shay et al., 2009).

A third, practically relevant property is that ALA influences glucose transport into muscle cells, partly activating the same pathways as muscular work. This is why a large share of ALA research sits in a metabolic context.

The complaints people associate with needing ALA

Since no deficiency is diagnosed, the "symptoms" are really situations where oxidative load is higher or glucose metabolism is strained. Honestly, they are non-specific and in most cases the cause lies elsewhere:

• Persistent fatigue that sleep does not fix. Before thinking about ALA, check iron, ferritin, vitamin D and thyroid. Those are far more common in Estonia and they can actually be measured.
• Tingling or numbness in fingers and toes. This needs a doctor's assessment, not a supplement. ALA has been studied in this context, but always under medical supervision.
• Unstable energy and strong sugar cravings after a carbohydrate-heavy meal. This is where the theoretical logic for ALA is strongest, but a lifestyle change gives more.
• A heavy training load combined with low vegetable intake. In an Estonian winter that is a fairly common pattern.
• Regular alcohol intake, which raises oxidative load and depletes glutathione reserves.

If fatigue is your only complaint, the chance that ALA is the answer is small. If several of the above apply at once, a trial makes more sense.

Forms: R-ALA, S-ALA and the racemic mix

A practical nuance you will not read on the label: free R-lipoic acid is unstable and polymerises with heat, whereas the sodium salt form gives a substantially higher and more consistent plasma concentration (Carlson et al., 2007). If you buy the R form, check whether it is a stabilised salt.

What the research actually shows

ALA is better researched than most niche supplements, but the bulk of that research was done in clinical groups, not in healthy athletes. That is an important distinction.

In the metabolic and body weight context there are two meta-analyses. A pooled analysis of randomised trials found that ALA supplementation was associated with a modest reduction in body weight and waist circumference compared with placebo (Kucukgoncu et al., 2017). A second systematic review of clinical trials in patients with obesity reached a similar conclusion, stressing that the effect is statistically present but clinically small (Namazi et al., 2018). Small here usually means under a kilogram over several months. If somebody sells you ALA as a fat burner, that is exactly where the promise and the data part ways.

For inflammatory markers, a meta-analysis in patients with metabolic syndrome and related disorders found that ALA reduced some circulating inflammatory markers (Akbari et al., 2018). Again: clinical groups, not a healthy person who wants to feel better.

The strongest evidence base sits in diabetic peripheral polyneuropathy, where ALA has been used under medical supervision in Germany for decades. The SYDNEY 2 trial showed an improvement in symptom scores with oral ALA (Ziegler et al., 2006), while the long-term NATHAN 1 trial did not meet its primary endpoint over four years, although some neuropathic findings improved (Ziegler et al., 2011). That is exactly the balanced picture you will not find in marketing material. And again: this is a medical context, not self-treatment.

Food versus supplement: the amounts are not comparable

Lipoic acid from food is almost entirely in the protein-bound form and the amounts are small — from micrograms up to a couple of milligrams a day from the best sources, which are organ meat, spinach, broccoli, tomato and Brussels sprouts. A typical supplement dose is 200-600 mg, that is hundreds of times more, and in free form.

Two conclusions follow. First: you cannot run an ALA trial through food, the amounts do not allow it. Second: the fact that a compound occurs in food does not mean a large free-form dose is automatically safe at any amount. Most studies use 300-600 mg a day and those doses are well tolerated, but that is not a reason to take 1200 mg.

Who should skip this

• If you use blood-glucose-lowering medication or insulin, do not start ALA without speaking to your doctor. ALA can influence glucose metabolism and that combination needs supervision.
• If you have thyroid disease or take thyroid hormone, discuss it with your doctor.
• Pregnancy and breastfeeding: there is not enough safety data, so it is not a sensible choice.
• If your B vitamin status, particularly thiamine, is poor, fix that first. Adding ALA does not replace a missing base.
• If you have a sensitive stomach, ALA on an empty stomach is a frequent cause of nausea. See the dosing section below.
• And most importantly: if you have numbness, tingling or another neurological symptom of unknown cause, the first step is a doctor, not a supplement.

Dosing and timing

The common dose in studies is 300-600 mg a day for the racemic form. For the R form roughly half that amount is typically used.

Timing matters unusually much with ALA. Absorption drops noticeably when it is taken with a meal, so the usual advice is 30 minutes before eating or two hours after. At the same time, an empty stomach is exactly what causes nausea in some people. A practical compromise: start with 200 mg after a light snack, watch tolerance for a week, and only then move towards an empty stomach and a larger dose.

Trial length: if nothing has changed after three to four months, there is no reason to continue. That is a more honest approach than renewing the jar forever.

What is available in Estonia and what it costs

The ALA selection in Estonia is considerably narrower than in large markets. Usually there are two or three products on the shelf, and a stabilised R-form salt is a rare find here — it often has to be special-ordered. If you simply want an ordinary dose, NOW Alpha Lipoic Acid 250mg 60 veg caps costs 17.90 € at the time of writing, which works out at about 0.30 € a day over a two-month trial.

If you prefer a combination product, MST Alpha Lipoic Acid 200mg + vitamin C 60caps costs 18.90 € at the time of writing. Adding vitamin C is logical here, since ALA regenerates vitamin C and vice versa, although no separate clinical advantage of the combination has been demonstrated. The full range is in the alpha-lipoic acid category.

Two practical observations in the Estonian context. First: in a pharmacy the price per gram is usually higher than in a supplement shop, even though the active compound is the same. Second: if your real problem is simply poor winter micronutrient coverage, a vitamin complex is a more sensible first purchase than a niche supplement. And if you train seriously but your daily protein is under one gram per kilo of body weight, then Optimum-nutrition Gold Standard 100% Whey 450g Vanillijäätis at 24.90 € at the time of writing will do more for your actual results than any antioxidant; more options are in the protein category.

ALA and training: can an antioxidant get in the way?

Here is a nuance most supplement texts stay quiet about. Training itself generates reactive species, and that signal is what triggers part of the adaptation — mitochondrial growth and the strengthening of your own antioxidant system. Large antioxidant doses right around a session can partly blunt that signal. This has been discussed most for high doses of vitamins C and E, but the same logic applies in principle to any strong antioxidant.

The practical conclusion is not "do not take it" but "do not take it around training". If you use ALA, take it in the morning or the evening, not an hour before the gym or straight after. If your goal is strength or muscle mass, stacking antioxidants around training is the worst timing you can choose.

A second practical point: ALA is not a pre-workout product. It does not give energy in the way caffeine does, and you should not expect a subjective push. If you take it for three days and feel nothing, that is exactly as expected, not a sign of a bad product.

How to tell whether it works at all

The biggest problem with supplements aimed at vague complaints is that the verdict is made from memory, and memory is biased. If you bought the jar, you want it to work.

Do this instead. Before starting, write down two or three concrete things you will track: for example energy level around 3 pm on a 1-10 scale, the strength of evening sugar cravings, and one objective number you measure anyway. Rate them three times a week rather than daily. After eight weeks, look at the whole series.

Change only one thing at a time. If you start ALA, a new training programme and a lower-carbohydrate diet in the same week, you will never know what did what. In Estonia that is especially common in January, when everything changes at once.

And finish honestly. If eight weeks give you nothing, put the jar aside. A supplement budget is limited, and every euro that goes into a niche product that does nothing is a euro that did not go to protein, vitamin D or magnesium, where the odds are considerably better.

Interactions and what to watch

ALA binds metals, so it should not be taken at the same time as an iron or zinc preparation. Leave at least two hours between them.

If you monitor blood glucose, measure more often than usual during the first weeks, because ALA can shift the glucose response.

The most frequent side effect is gastrointestinal discomfort and nausea, which is dose-dependent. Skin rash is described less often. If any new symptom appears, stop and talk to a doctor.

Three common mistakes

The first mistake is buying ALA as a fat burner. The meta-analysis effect exists but is small (Kucukgoncu et al., 2017; Namazi et al., 2018), and it does not outweigh diet or training.

The second mistake is starting straight at a large dose with breakfast. A large dose with food means worse absorption and a higher nausea risk at the same time.

The third mistake is using ALA to avoid seeing a doctor about a neurological symptom. That is the one point in this article that is serious.

FAQ

Can I test for an ALA deficiency?

No, there is no routine clinical test for free lipoic acid levels and no classical deficiency has been described. If you have fatigue or neurological complaints, it makes sense to test iron, ferritin, vitamin D, B12 and thyroid function.

R-ALA or ordinary ALA?

For most people the ordinary racemic form is enough and it is cheaper. The R form gives a higher plasma level at a smaller dose (Carlson et al., 2007), which helps if a large dose causes nausea.

Does ALA help with weight loss?

Meta-analyses show a statistically significant but clinically small effect (Namazi et al., 2018). A realistic expectation is a small addition, not a solution.

Can ALA be combined with NAC or glutathione?

The theoretical logic exists, since they act in the same antioxidant network, but human studies on the combination are scarce. If you start, start with one compound at a time, otherwise you will never know what did what.

Do I have to take it forever?

No. Give the trial three to four months, write down what you are tracking, and decide on that basis.

Does ALA interact with common medications?

The most important are blood-glucose-lowering drugs and thyroid hormones. Iron preparations should also be separated in time. Ask your pharmacist if you are on long-term medication.

If you are curious how ALA relates to other sulfur-containing compounds, see the article on NAC deficiency signs. The molybdenum article gives a good overview of trace element logic, and if your actual complaint is fatigue and muscle cramps, start with the Magne B6 guide instead.

References

Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009). Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta, 1790(10), 1149-1160. https://pubmed.ncbi.nlm.nih.gov/19664690/

Ziegler, D., Ametov, A., Barinov, A., Dyck, P. J., Gurieva, I., Low, P. A., ... & Samigullin, R. (2006). Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care, 29(11), 2365-2370. https://pubmed.ncbi.nlm.nih.gov/17065669/

Ziegler, D., Low, P. A., Litchy, W. J., Boulton, A. J., Vinik, A. I., Freeman, R., ... & Dyck, P. J. (2011). Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care, 34(9), 2054-2060. https://pubmed.ncbi.nlm.nih.gov/21775755/

Kucukgoncu, S., Zhou, E., Lucas, K. B., & Tek, C. (2017). Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obesity Reviews, 18(5), 594-601. https://pubmed.ncbi.nlm.nih.gov/28295905/

Namazi, N., Larijani, B., & Azadbakht, L. (2018). Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials. Clinical Nutrition, 37(2), 419-428. https://pubmed.ncbi.nlm.nih.gov/28629898/

Akbari, M., Ostadmohammadi, V., Tabrizi, R., Lankarani, K. B., Heydari, S. T., Amirani, E., ... & Asemi, Z. (2018). The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Metabolism, 15, 39. https://pubmed.ncbi.nlm.nih.gov/29930690/

Carlson, D. A., Smith, A. R., Fischer, S. J., Young, K. L., & Packer, L. (2007). The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Alternative Medicine Review, 12(4), 343-351. https://pubmed.ncbi.nlm.nih.gov/18069903/